Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B

Detalhes bibliográficos
Ano de defesa: 2017
Autor(a) principal: TROVÓ, Marco Aurélio lattes
Orientador(a): MURTA, Eddie Fernando Candido lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal do Triângulo Mineiro
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências da Saúde
Departamento: Instituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúde
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://bdtd.uftm.edu.br/handle/tede/646
Resumo: Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile.
id UFTM_80fecb109567d5249df56f43bd213682
oai_identifier_str oai:bdtd.uftm.edu.br:tede/646
network_acronym_str UFTM
network_name_str Biblioteca Digital de Teses e Dissertações da UFTM
repository_id_str
spelling MURTA, Eddie Fernando Candidohttp://lattes.cnpq.br/5724192420139830http://lattes.cnpq.br/7490788160201168TROVÓ, Marco Aurélio2019-05-06T12:58:39Z2017-04-17TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017.http://bdtd.uftm.edu.br/handle/tede/646Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile.A imunoterapia em pacientes com câncer é um tratamento muito promissor e o desenvolvimento de novos protocolos e o estudo dos mecanismos de regressão é uma realidade. Os interferons (IFNs) são glicoproteínas pertencentes à família das citocinas que por sua vez desempenham importante ação antiviral, antitumoral, imunomoduladora e atividades antiangiogênicas. Objetivo é traçar os perfis imunológicos Th1 e Th2 envolvidos em lesões cervicais de alto grau NIC II/NIC III por dosagem sérica de citocinas pelo método de Elisa em amostras de soro colhidos durante o tratamento por 6 semanas com IFN Peguilado 2-b administrado por via subcutânea. O perfil de resposta das pacientes foram analizadas em três intervalos de coleta sanguínea e avaliadas as citocinas IL-1ᵦ, IL-2, IL-4, TNF-a, IFN-y, IL-10, IL-12, TGF-beta, IL-12. Os grupos de análise foram divididos em boa e má resposta e comparados utilizando-se a mediana por Mann-Whitney test, Wilcoxon Matched Paires test e Kruskal-Wallis test pelo software GraphPad Prism 6®, e os valores de p menores que 0,05 (p<0.05) foram considerados estatisticamente significantes. Os resultados mostram que no grupo que houve regressão os pacientes apresentaram um aumento na quantidade de IFN-γ durante toda a imunoterapia, com significância estatística p=0,0123. Por outro lado, também mostrou um aumento da IL-6, IL-10 e TGF (perfil Th2) no grupo sem resposta. Amostra geral (n=17), houve uma regressão de 47% das lesões de alto grau. Concluimos que a regressão das lesões cervicais depende do perfil imunológico de cada paciente como também as mudanças nas respostas imune para um perfil Th1.application/pdfhttp://bdtd.uftm.edu.br/retrieve/4018/Dissert%20Marco%20A%20Trovo.pdf.jpgporUniversidade Federal do Triângulo MineiroPrograma de Pós-Graduação em Ciências da SaúdeUFTMBrasilInstituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúdehttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessImunoterapia.Neoplasia intraepitelial cervica.Interleucinas.Immunotherapy.Cervical intraepithelial neoplasia.Interleukins.ImunoterapiaDosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-Binfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisreponame:Biblioteca Digital de Teses e Dissertações da UFTMinstname:Universidade Federal do Triangulo Mineiro (UFTM)instacron:UFTMLICENSElicense.txtlicense.txttext/plain; charset=utf-81976http://bdtd.uftm.edu.br/bitstream/tede/646/1/license.txt1e1650138dd271baea0105346966c99cMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://bdtd.uftm.edu.br/bitstream/tede/646/2/license_url4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://bdtd.uftm.edu.br/bitstream/tede/646/3/license_textd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://bdtd.uftm.edu.br/bitstream/tede/646/4/license_rdfd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissert Marco A Trovo.pdfDissert Marco A Trovo.pdfDissert Marco A Trovoapplication/pdf2197967http://bdtd.uftm.edu.br/bitstream/tede/646/5/Dissert%20Marco%20A%20Trovo.pdf1c48f68016390c279f5ddb5566976e54MD55TEXTDissert Marco A Trovo.pdf.txtDissert Marco A Trovo.pdf.txtExtracted Texttext/plain133163http://bdtd.uftm.edu.br/bitstream/tede/646/6/Dissert%20Marco%20A%20Trovo.pdf.txt68a880be4b4427fb67155a6435277cfbMD56THUMBNAILDissert Marco A Trovo.pdf.jpgDissert Marco A Trovo.pdf.jpgGenerated Thumbnailimage/jpeg1954http://bdtd.uftm.edu.br/bitstream/tede/646/7/Dissert%20Marco%20A%20Trovo.pdf.jpga8c0fa900a1e54d69b435465e2fd7e82MD57tede/6462019-05-07 01:00:16.467oai:bdtd.uftm.edu.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://bdtd.uftm.edu.br/PUBhttp://bdtd.uftm.edu.br/oai/requestbdtd@uftm.edu.br||bdtd@uftm.edu.bropendoar:2019-05-07T04:00:16Biblioteca Digital de Teses e Dissertações da UFTM - Universidade Federal do Triangulo Mineiro (UFTM)false
dc.title.por.fl_str_mv Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
title Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
spellingShingle Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
TROVÓ, Marco Aurélio
Imunoterapia.
Neoplasia intraepitelial cervica.
Interleucinas.
Immunotherapy.
Cervical intraepithelial neoplasia.
Interleukins.
Imunoterapia
title_short Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
title_full Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
title_fullStr Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
title_full_unstemmed Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
title_sort Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
author TROVÓ, Marco Aurélio
author_facet TROVÓ, Marco Aurélio
author_role author
dc.contributor.advisor1.fl_str_mv MURTA, Eddie Fernando Candido
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/5724192420139830
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7490788160201168
dc.contributor.author.fl_str_mv TROVÓ, Marco Aurélio
contributor_str_mv MURTA, Eddie Fernando Candido
dc.subject.por.fl_str_mv Imunoterapia.
Neoplasia intraepitelial cervica.
Interleucinas.
topic Imunoterapia.
Neoplasia intraepitelial cervica.
Interleucinas.
Immunotherapy.
Cervical intraepithelial neoplasia.
Interleukins.
Imunoterapia
dc.subject.eng.fl_str_mv Immunotherapy.
Cervical intraepithelial neoplasia.
Interleukins.
dc.subject.cnpq.fl_str_mv Imunoterapia
description Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile.
publishDate 2017
dc.date.issued.fl_str_mv 2017-04-17
dc.date.accessioned.fl_str_mv 2019-05-06T12:58:39Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017.
dc.identifier.uri.fl_str_mv http://bdtd.uftm.edu.br/handle/tede/646
identifier_str_mv TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017.
url http://bdtd.uftm.edu.br/handle/tede/646
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do Triângulo Mineiro
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv UFTM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Instituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal do Triângulo Mineiro
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFTM
instname:Universidade Federal do Triangulo Mineiro (UFTM)
instacron:UFTM
instname_str Universidade Federal do Triangulo Mineiro (UFTM)
instacron_str UFTM
institution UFTM
reponame_str Biblioteca Digital de Teses e Dissertações da UFTM
collection Biblioteca Digital de Teses e Dissertações da UFTM
bitstream.url.fl_str_mv http://bdtd.uftm.edu.br/bitstream/tede/646/1/license.txt
http://bdtd.uftm.edu.br/bitstream/tede/646/2/license_url
http://bdtd.uftm.edu.br/bitstream/tede/646/3/license_text
http://bdtd.uftm.edu.br/bitstream/tede/646/4/license_rdf
http://bdtd.uftm.edu.br/bitstream/tede/646/5/Dissert%20Marco%20A%20Trovo.pdf
http://bdtd.uftm.edu.br/bitstream/tede/646/6/Dissert%20Marco%20A%20Trovo.pdf.txt
http://bdtd.uftm.edu.br/bitstream/tede/646/7/Dissert%20Marco%20A%20Trovo.pdf.jpg
bitstream.checksum.fl_str_mv 1e1650138dd271baea0105346966c99c
4afdbb8c545fd630ea7db775da747b2f
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
1c48f68016390c279f5ddb5566976e54
68a880be4b4427fb67155a6435277cfb
a8c0fa900a1e54d69b435465e2fd7e82
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFTM - Universidade Federal do Triangulo Mineiro (UFTM)
repository.mail.fl_str_mv bdtd@uftm.edu.br||bdtd@uftm.edu.br
_version_ 1865641840895590400